Real ChatGPT answer · index seedaPt3Dc33g2kcompleteHealth and wellness · supplements and vitaminscommercial
Which prescription-strength or clinical-grade fat burners actually work for visceral fat reduction when paired with intermittent fasting?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Which prescription-strength or clinical-grade fat burners actually work for visceral fat reduction when paired with intermittent fasting?
3 real searches · 1 real-search pass
2026 clinical evidence tirzepatide semaglutide visceral adipose tissue reduction obesity MRI trialGoogle ↗
OBSERVED
FDA approved chronic weight management medications 2026 semaglutide tirzepatide phentermine topiramate orlistat prescribing informationGoogle ↗
OBSERVED
intermittent fasting visceral fat reduction randomized trial evidence obesityGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 clinical evidence tirzepatide semaglutide visceral adipose tissue reduction obesity MRI trial Google ↗
FDA approved chronic weight management medications 2026 semaglutide tirzepatide phentermine topiramate orlistat prescribing information Google ↗
intermittent fasting visceral fat reduction randomized trial evidence obesity Google ↗
- Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026) · doi.org
- Prescription Medications to Treat Overweight & Obesity · niddk.nih.gov
- FDA Approves New Medication for Chronic Weight Management · fda.gov
- Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial · nature.com
- Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial. · pubmed.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 clinical evidence tirzepatide semaglutide visceral adipose tissue reduction obesity MRI trial OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA approved chronic weight management medications 2026 semaglutide tirzepatide phentermine topiramate orlistat prescribing information OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
intermittent fasting visceral fat reduction randomized trial evidence obesity OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |